dc.creator | Monici L.T. | |
dc.creator | Zeitune J.M.R. | |
dc.creator | Lorena S.L.S. | |
dc.creator | Mesquita M.A.A. | |
dc.creator | De Magalhaes A.F.N. | |
dc.date | 2003 | |
dc.date | 2015-06-30T17:26:59Z | |
dc.date | 2015-11-26T15:39:06Z | |
dc.date | 2015-06-30T17:26:59Z | |
dc.date | 2015-11-26T15:39:06Z | |
dc.date.accessioned | 2018-03-28T22:47:37Z | |
dc.date.available | 2018-03-28T22:47:37Z | |
dc.identifier | | |
dc.identifier | Revista Brasileira De Medicina. , v. 60, n. SPEC. ISS., p. 25 - 32, 2003. | |
dc.identifier | 347264 | |
dc.identifier | | |
dc.identifier | http://www.scopus.com/inward/record.url?eid=2-s2.0-0742305954&partnerID=40&md5=ee66d8021e281517a106d5fed8f9591d | |
dc.identifier | http://www.repositorio.unicamp.br/handle/REPOSIP/102024 | |
dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/102024 | |
dc.identifier | 2-s2.0-0742305954 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1264064 | |
dc.description | Peptic ulcer is a common disease. The Helicobacter pylori infection and the use of anti-inflammatory drugs are the main risk factors. There is no characteristic clinical finding and some patients have no symptom. Epigastric pain is a common finding and is associated with food. The diagnosis is done by upper gastrointestinal endoscopy and endoscopic biopsies can identificate H.pylori. Eradication of the organism is the therapy of choice in infected patients. Drugs that inhibit acid gastric secretion can promote ulcer healing in almost all patients. The protom pump inhibitors are the most effective. They can be used in prevention of ulcer in high risk patients that use anti-inflammatory, as in elderly, patients with severe comorbid conditions and patients taking corticosteroids or anticoagulants. | |
dc.description | 60 | |
dc.description | SPEC. ISS. | |
dc.description | 25 | |
dc.description | 32 | |
dc.description | Kurata, J.H., Epidemiology of peptic ulcer disease (1984) Clin Gastroenterol, 13, p. 289 | |
dc.description | Munnangi, S., Time trends of physician visits and treatment patterns of peptic ulcer disease in the United States (1997) Arch Intern Med, 157, pp. 1489-1494 | |
dc.description | Higham, J., Kang, J.Y., Majeed, A., Recent trends in admissions and mortality due to peptic ulcer in England: Increasing frequency of haemorrhage among older subjects (2002) Gut, 50, pp. 460-464 | |
dc.description | Marshall, B.J., Warren, J.R., Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulcerations (1984) Lancet, 1, pp. 1311-1315 | |
dc.description | Cohen, H., Peptic ulcer and Helicobacter pylori (2000) Gastroenterol Clin North Am, 29, p. 775 | |
dc.description | El-Omar, E.M., Penman, I.D., Ardill, J.E., Chittajallu, R.S., Howie, C., McColl, K.E., Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease (1995) Gastroenterology, 109, pp. 681-691 | |
dc.description | Beales, I., Calam, J., Post, L., Effect of transforming growth factor alpha and interleukin 8 on somatostatin release from canine fundic D cells (1997) Gastroenterology, 112, pp. 136-143 | |
dc.description | Hogan, D.L., Rapier, R.C., Dreilinger, A., Duodenal bicarbonate secretion: Eradication of Helicobacter pylori and duodenal structure and function in humans (1996) Gastroenterology, 110, pp. 705-716 | |
dc.description | Segal, E.D., Cha, J., Lo, J., Falkow, S., Tompkins, L.S., Altered states: Involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori (1999) Proc Natl Acad Sci USA, 96, pp. 14559-14564 | |
dc.description | Uemura, N., Okamoto, S., Yamamoto, S., Helicobacter infection and the development of gastric cancer (2001) N Engl J Med, 345, pp. 784-789 | |
dc.description | Wolfe, M.M., Lichtenstein, D.R., Singh, G., Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs (1999) N Engl J Med, 340, p. 1888 | |
dc.description | Wallace, J.L., Keenan, C.M., Granger, D.N., Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process (1990) Am J Physiol, 259, pp. 462-467 | |
dc.description | Silverstein, F.E., Faich, G., Goldstein, J.L., Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflamamatory drugs for osteoarthritis and rheumatoid arthritis (2000) JAMA, 284, pp. 1247-1255 | |
dc.description | Wallace, J.L., McKnight, W., Reuter, B.K., Vergnolle, N., NSAID-induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase 1 and 2 (2000) Gastroenterology, 119, pp. 706-714 | |
dc.description | Huang, J.Q., Sridhar, S., Hunt, R.H., Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: A meta-analysis (2002) Lancet, 359, pp. 14-22 | |
dc.description | Zeitune, J.M.R., Monici, L.T., Nishimura, N.F., Diagnóstico da infecção pelo Helicobacter pylori (2000) Gastroenterologia III/Farid Nader, , Pelotas: Editora Universitária | |
dc.description | Borody, T.J., Cole, P., Noonan, S., Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication (1989) Med J Aust, 151, pp. 431-435 | |
dc.description | Porro, G.B., Parente, F., Antacids for duodenal ulcer: Current role (1990) Scand J Gastroenterol, 25, p. 48 | |
dc.description | Deakin, M., Williams, J.G., Histamine H2-receptor antagonists in peptic ulcer disease. Efficacy in healing peptic ulcers (1992) Drugs, 44, p. 709 | |
dc.description | Lee, F.I., Collin-Jones, D.G., Golding, P.L., Double-blind comparative study of omeprazole and ranitidine in patients with duodenal or gastric ulcer: A multicentre trial (1991) Gut, 26, p. 137 | |
dc.description | Malfertheiner, P., Megraud, F., O'Morain, C., Current concepts in the management of Helicobacter pylori infection: The Maastricht 2-2000 Consensus Report (2002) Aliment Pharmacol Ther, 16, pp. 167-180 | |
dc.description | Vaira, D., Vakil, N., Menegatti, M., The stool antigen test for detection of Helicobacter pylori after eradication therapy (2002) Ann Intern Med, 136, pp. 280-287 | |
dc.description | Yeomans, N.D., Tulassay, Z., Juhasz, L., Omeprazole compared with ranitidine for ulcers associated with nonsteroidal antiinflamatory drugs (1998) N Engl J Med, 338, pp. 719-726 | |
dc.description | Rich, M., Scheiman, J., Nonsteroidal anti-inflammatory drug gastropathy at the new millennium: Mechanisms and prevention (2000) Sem Arthritis Rheum, 30, p. 167 | |
dc.description | Norton, J., Surgery to cure Zollinger-Ellison syndrome (1999) N Engl J Med, 341, p. 635 | |
dc.language | pt | |
dc.publisher | | |
dc.relation | Revista Brasileira de Medicina | |
dc.rights | fechado | |
dc.source | Scopus | |
dc.title | Peptic Ulcer [Úlcera Péptica] | |
dc.type | Artículos de revistas | |